Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
2026 ASCRS Meeting Adds Patriotic Pomp, Lighter Features to Program
A wave of IOL launches dominated the 2026 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), highlighting intensifying competition across the premium IOL space. But confere...
IOL Makers Go All in to Launch Premium Lenses at ASCRS Meeting
Johnson & Johnson Vision, BVI Medical, and Alcon showcased the strengths of their latest IOLs throughout the 2026 ASCRS meeting, explaining how their technology benefits the growing premium space. ...
Generics, New Drug Classes, Sustained Release Dosing Shape Glaucoma Pharma Market
The glaucoma pharmaceuticals market is showing signs of emerging from its prolonged revenue slump. One cycle of conversions from proprietary drugs to generic drugs is nearing an end, and a new cycl...
Myopia Management Market Poised for Growth with Recent Product Advancements
Recent moves by eye care companies suggest that the myopia management market is entering a new phase. In September 2025, Essilor gained US marketing authorization for the Stellest, the first specta...
Bayer to Acquire Perfuse in Deal Worth Up to $2.45 Billion
German drugmaker Bayer announced May 6 that it would acquire Perfuse Therapeutics in a deal worth up to $2.45 billion. Perfuse, of South San Francisco, California, is advancing PER-001 for glaucoma...
Revenio Group to Acquire Visionix in $341 Million Deal
Finland’s Revenio Group, parent of ophthalmic diagnostic company iCare, announced April 13 that it would acquire France-based Visionix in a deal worth €290 million ($341 million). Revenio said that...
Select US FDA Approvals and Clearances in April 2026
The US FDA’s ophthalmic device division granted clearance to four devices using the 510(k) pathway in April 2026, according to the agency’s database. Retmap received clearance for its RM Electrode,...
PDUFA Dates for Ophthalmic Drug Candidates
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
US CMS Issues J-Codes and Q-Codes for Four Ophthalmic Products in Q1-2026
The US Centers for Medicare and Medicaid Services (CMS) issued J-codes in Q1-2026 for Harrow’s Iopidine and Glaukos’ Epioxa and Epioxa HD. In addition, the CMS issued Q-codes for Zydec’s interchang...
Santen to Market Five of AbbVie’s Glaucoma Drops in Mainland China
Japan’s Santen Pharmaceutical announced April 17 that its China subsidiary had entered into a distribution and promotion agreement with AbbVie for five marketed glaucoma eye drops in the Chinese ma...
Viridian Leads Latest Fundraising with $250 Million in Public Offerings
Viridian Therapeutics led recent ophthalmic fundraising efforts with $250 million in public offerings of convertible notes and Series B stock to advance its TED candidates. Financing announced in t...
Bausch + Lomb Launches Bi-Blade+ Dual-Port Vitrectomy Cutter in Europe
Bausch + Lomb announced May 7 the European launch of the Bi-Blade+ dual-port vitrectomy cutter on the Stellaris Elite dual-function cataract and vitrectomy system. The Bi-Blade+ now offers 25 thous...
Past News Stories
2026-2027 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
Glaukos Debuts Epioxa Epi-On Crosslinking at 2026 ASCRS Meeting
Glaukos launched Epioxa during the 2026 ASCRS meeting in April after announcing the product’s commercial availability in March. The company also shared plans to support access through patient assis...
Cellution Launches OptiCover Amniotic Graft at ASCRS Meeting
Cellution Biologics launched its OptiCover amniotic graft for ocular use at the 2026 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), which ran April 10-13 in Washington,...
Surgeons Share Experience With Three of Rayner’s Technologies
Ophthalmologists took a deep dive into describing their experience with two of Rayner’s newest IOLs—the RayOne Galaxy and RayOne EMV Toric—along with the company’s Sophi phaco system at a Rayner-sp...
Emerging Companies Pursuing Ophthalmic Indications, May 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
Pioneering Eye Charities Team Up to Provide Cataract Surgery in Rwanda, Laos, Other Countries
Cure Blindness Project and The Fred Hollows Foundation reported April 2 that they are partnering to end avoidable blindness in Rwanda and Laos by 2035. In addition, they will address the cataract s...
Clinical Trial Updates for Ophthalmic Candidates, May 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
New Tennessee Law Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy
Tennessee has become the 16th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 2076, signed into law by Gov. Bill Lee on April 14,...
Inventors of Luxturna Win $3 Million Breakthrough Prize
Penn Medicine’s Jean Bennett, MD, PhD, and Albert Maguire, MD, along with Katherine High, MD, of Children’s Hospital of Philadelphia (CHOP), have been awarded a prestigious Breakthrough Prize in Li...
Scientists Deliver Healthy Mitochondria to Sick Cells, Including Eye Cells
Swiss scientists reported April 15 that they had developed a technology that can deliver healthy mitochondria directly to cells most affected by disease. They called their approach a major step tow...
Weekly Poll of MDs, US and Western Europe, May 2026
May 2026 Ophthalmic News Briefs
Jupiter, Florida-based Ligand Pharmaceuticals and Xoma Royalty Corporation, of Emeryville, California, announced April 27 that Ligand would acquire Xoma for $39 per share of common stock in cash, f...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.